Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06022159
PHASE2

A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

Sponsor: Institut Claudius Regaud

View on ClinicalTrials.gov

Summary

This is a phase II, multicenter, non-randomized study. The main objective is to evaluate the treatment with hypofractionated radiation therapy in neo-adjuvant situations on wound healing in a population of aged patients (≥ 70 years old) or ≥ 65 years of age defined as "fragile" and treated for soft tissue sarcoma. A maximum of 48 evaluable patients will be included in this study. The patients will receive an hypofractionated radiation therapy prior to conservative surgery. Each patient will be followed for up to 3 years after the end of complete treatment (radiotherapy + surgery).

Official title: Phase II Study Evaluating Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

Key Details

Gender

All

Age Range

65 Years - Any

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2023-11-28

Completion Date

2029-05

Last Updated

2025-06-05

Healthy Volunteers

No

Interventions

RADIATION

Hypofractionated Radiation Therapy

The Hypofractionated Intensity-Modulated Radiation Therapy will be delivered in 5 fractions of 6 Gy each on the Planning Target Volume (PTV). The total dose of 30 Gy will be administered in approximately 1 week.

PROCEDURE

Conservative treatment

A wide en bloc resection is required (amputation is excluded) while ensuring the best functional preservation. The surgical procedure will take place about 1,5 to 2 months after the end of the radiation therapy.

Locations (11)

Institut Bergonie

Bordeaux, France

Centre Oscar Lambret

Lille, France

Chu de Limoges

Limoges, France

Centre Leon Berard

Lyon, France

Institut Regional Du Cancer de Montpellier

Montpellier, France

Institut Curie

Paris, France

Chu de Poitiers

Poitiers, France

Institut de Cancerologie de L'Ouest

Saint-Herblain, France

Chu de Toulouse

Toulouse, France

IUCT-O

Toulouse, France

Institut Gustave Roussy

Villejuif, France